Hc1 turned its attention to opioid data late last year after realizing the crisis was ripe for artificial intelligence-driven analysis, Bostic says, because the associated data tends to be broad, in multiple formats, and inconsistent. On hc1's opioid dashboard, the company is partnering with drug-testing labs from ...

Read more